Ming‐Ling Chang

2.6k citations

121 papers · 1.9k indexed · h-index 22

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in ⓘ

Hepatology 90
- Hepatitis C virus research 68
- Liver Diseases and Immunity 9
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Liver Disease and Transplantation 7
- Hepatitis Viruses Studies and Epidemiology 6
Epidemiology 90
- Liver Disease Diagnosis and Treatment 73
- Hepatitis B Virus Studies 51

Co-authors: Yun‐Fan Liaw (18 shared papers)Chau‐Ting Yeh (46 shared papers)Sien‐Sing Yang (4 shared papers)Rong‐Nan Chien (36 shared papers)Chao‐Wei Hsu (17 shared papers)Stephanos J. Hadziyannis (1 shared paper)Kung‐Hao Liang (14 shared papers)Ming‐Wei Lai (8 shared papers)
Journals: Journal of Medical Virology (7 papers)Scientific Reports (5 papers)Journal of Clinical Medicine (5 papers)PLoS ONE (5 papers)Journal of Hepatology (4 papers)
Partner nations: Taiwan United States Sweden

In The Last Decade

Ming‐Ling Chang

117 papers receiving 1.9k citations

Peers

Countries citing papers authored by Ming‐Ling Chang

Since Specialization

Citations

This map shows the geographic impact of Ming‐Ling Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Ling Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Ling Chang more than expected).

Fields of papers citing papers by Ming‐Ling Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Ling Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Ling Chang. The network helps show where Ming‐Ling Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming‐Ling Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming‐Ling Chang Line = papers co-authored together Ming‐Ling Chang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management Journal of Hepatology ·Ming‐Ling Chang, Yun‐Fan Liaw	2014	210
2	Metabolic alterations and hepatitis C: From bench to bedside World Journal of Gastroenterology ·Ming‐Ling Chang	2016	102
3	Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B Alimentary Pharmacology & Therapeutics ·Ming‐Ling Chang, Yun‐Fan Liaw, Stephanos J. Hadziyannis	2015	95
4	Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma PLoS ONE ·Ya‐Hui Huang, Kwang‐Huei Lin, Hua‐Chien Chen, Ming‐Ling Chang, Chao‐Wei Hsu, Ming‐Wei Lai, Tse‐Ching Chen, Wei‐Chen Lee, Yi‐Hsin Tseng, Chau‐Ting Yeh	2012	77
5	Hepatitis B Virus–DNA Level and Basal Core Promoter A1762T/G1764A Mutation in Liver Tissue Independently Predict Postoperative Survival in Hepatocellular Carcinoma Hepatology ·Chau‐Ting Yeh, Mary So, Jennifer Ng, Hanwen Yang, Ming‐Ling Chang, Ming‐Wei Lai, Tse‐Ching Chen, Chun‐Yen Lin, Ta‐Sen Yeh, Wei‐Chen Lee	2010	73
6	Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression International Journal of Molecular Sciences ·Ming‐Ling Chang, Zinger Yang, Sien‐Sing Yang	2020	66
7	Peginterferon Is Superior to Nucleos(t)ide Analogues for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B The Journal of Infectious Diseases ·Kung‐Hao Liang, Chao‐Wei Hsu, Ming‐Ling Chang, Yi‐Cheng Chen, Ming‐Wei Lai, Chau‐Ting Yeh	2015	62
8	Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology Cells ·Ming‐Ling Chang, Sien‐Sing Yang	2019	58
9	Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation World Journal of Gastroenterology ·Ming‐Ling Chang	2005	49
10	Identification of a Hepatitis B Virus S Gene Mutant in Lamivudine-Treated Patients Experiencing HBsAg Seroclearance Gastroenterology ·Chao‐Wei Hsu, Chau‐Ting Yeh, Ming‐Ling Chang, Yun‐Fan Liaw	2006	38
11	Plasminogen activator inhibitor‐1 is independently associated with non‐alcoholic fatty liver disease whereas leptin and adiponectin vary between genders Journal of Gastroenterology and Hepatology ·Ming‐Ling Chang, Chen‐Ming Hsu, Jeng‐Hwei Tseng, Yung‐Kuan Tsou, Shuchun Chen, Shuen‐Shian Shiau, Chau‐Ting Yeh, Cheng‐Tang Chiu	2014	36
12	Identification of variations in the human phosphoinositide 3‐kinase p110δ gene in children with primary B‐cell immunodeficiency of unknown aetiology International Journal of Immunogenetics ·Shiann‐Tarng Jou, Yin‐Hsiu Chien, Yao‐Hsu Yang, Ting Wang, Shyh‐Dar Shyur, Chi‐Chung Chou, Ming‐Ling Chang, Dong‐Tsamn Lin, Kai‐Hsin Lin, Bor‐Luen Chiang	2006	35
13	Gallic Acid Ameliorated Impaired Lipid Homeostasis in a Mouse Model of High-Fat Diet—and Streptozotocin-Induced NAFLD and Diabetes through Improvement of β-oxidation and Ketogenesis Frontiers in Pharmacology ·Jung Chao, Hao‐Yuan Cheng, Ming‐Ling Chang, Shyh‐Shyun Huang, Jiunn‐Wang Liao, Yung‐Chi Cheng, Wen‐Huang Peng, Li‐Heng Pao	2021	34
14	Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B Journal of Hepatology ·Ming‐Ling Chang, Rong‐Nan Chien, Chau‐Ting Yeh, Yun‐Fan Liaw	2005	31
15	Clinical Events After Cessation of Lamivudine Therapy in Patients Recovered From Hepatitis B Flare With Hepatic Decompensation Clinical Gastroenterology and Hepatology ·Ming‐Ling Chang, Wen‐Juei Jeng, Yun‐Fan Liaw	2014	31
16	Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis World Journal of Gastroenterology ·Ming‐Ling Chang	2005	29
17	Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses International Journal of Molecular Sciences ·Ming‐Ling Chang, Yun‐Fan Liaw	2022	29
18	Multidrug resistance: The clinical dilemma of refractory Helicobacter pylori infection Journal of Microbiology Immunology and Infection ·Chia‐Jung Kuo, Cheng‐Han Lee, Ming‐Ling Chang, Cheng‐Yu Lin, Wey‐Ran Lin, Ming‐Yao Su, Cheng‐Hsun Chiu, Chi‐Nan Tseng, Yu‐Shan Wu, Cheng‐Tang Chiu, Chih‐Ho Lai	2021	28
19	A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma International Journal of Cancer ·Chau‐Ting Yeh, Kung‐Hao Liang, Chen‐Chun Lin, Ming‐Ling Chang, Cheng‐Lung Hsu, Chien‐Fu Hung	2013	28
20	Viral Load in Blood Is Correlated with Disease Severity of Neonatal Coxsackievirus B3 Infection: Early Diagnosis and Predicting Disease Severity Is Possible in Severe Neonatal Enterovirus Infection Clinical Infectious Diseases ·Mao‐Hsu Yen, K Tsao, Y.-C. Huang, Congxin Huang, Y.-L. Huang, Rui Lin, Ming‐Ling Chang, Chiu‐Ching Huang, Dah‐Chin Yan, Tzou‐Yien Lin	2007	27

About Ming‐Ling Chang

Ming‐Ling Chang is a scholar working on Hepatology, Epidemiology, Rheumatology, Endocrinology, Diabetes and Metabolism and Hematology, having authored 121 papers that have together received 1.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (73 papers), Hepatitis C virus research (68 papers), Hepatitis B Virus Studies (51 papers), Liver Diseases and Immunity (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease and Transplantation (7 papers), Hepatitis Viruses Studies and Epidemiology (6 papers) and Systemic Lupus Erythematosus Research (6 papers). The work is most often cited by research in Hepatology (1.1k citations), Epidemiology (1.2k citations), Cancer Research (157 citations), Immunology (155 citations) and Pharmacology (57 citations). Ming‐Ling Chang has collaborated with scholars based in Taiwan, United States and Sweden. Frequent co-authors include Yun‐Fan Liaw, Chau‐Ting Yeh, Sien‐Sing Yang, Rong‐Nan Chien, Chao‐Wei Hsu, Stephanos J. Hadziyannis, Kung‐Hao Liang, Ming‐Wei Lai, Yi‐Cheng Chen and Zinger Yang. Their work appears in journals such as Journal of Medical Virology, Scientific Reports, Journal of Clinical Medicine, PLoS ONE and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact